Ensuring equitable access to vaccines for refugees and migrants during the COVID-19 pandemic

Bartovic, Jozef; Datta, Siddharta Sankar; Severoni, Santino; D'Anna, Veronika

doi:10.2471/blt.20.267690

Cited by 33 publications

(23 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, refugee communities with language barriers and barriers to health care are at risk of being left behind during the complex and rapidly evolving COVD-19 vaccine rollout in the United States. [1][2][3] Barriers to immunization among refugee and other newcomer communities include insufficient access to health care before the pandemic, knowledge gaps about available vaccines, and vaccine hesitancy. 4,5 These barriers are believed to be closely interrelated.…”

mentioning

confidence: 99%

Acceptance of COVID-19 Vaccine Among Refugees in the United States

et al. 2021

View full text Add to dashboard Cite

Objective Little is known about COVID-19 vaccination intentions among refugee communities in the United States. The objective of this study was to measure COVID-19 vaccination intentions among a sample of refugees in the United States and the reasons for their vaccine acceptance or hesitancy. Methods From December 2020 through January 2021, we emailed or text messaged anonymous online surveys to 12 bilingual leaders in the Afghan, Bhutanese, Somali, South Sudanese, and Burmese refugee communities in the United States. We asked community leaders to complete the survey and share the link with community members who met the inclusion criteria (arrived in the United States as refugees, were aged ≥18, and currently lived in the United States). We compared the characteristics of respondents who intended to receive the COVID-19 vaccine with those of respondents who did not intend to receive the vaccine or were unsure. We then conducted crude and adjusted logistic regression analysis to measure the association between employment as an essential worker and COVID-19 vaccine acceptance. Results Of 435 respondents, 306 (70.3%) indicated that they planned to receive a COVID-19 vaccine. Being an essential worker (adjusted odds ratio [aOR] = 2.37; 95% CI, 1.44-3.90) and male sex (aOR = 1.87; 95% CI, 1.12-3.12) were significantly associated with higher odds of intending to receive a COVID-19 vaccine. Among respondents who intended to receive a COVID-19 vaccine, wanting to protect themselves (68.6%), family members (65.0%), and other people (54.3%) were the main reasons. Conclusion Many refugees who responded to the survey, especially those who worked in essential industries, intended to receive a COVID-19 vaccine. Community organizations, health care providers, and public health agencies should work together to ensure that vaccine registration and vaccination sites are accessible to refugees.

show abstract

mentioning

confidence: 99%

Acceptance of COVID-19 Vaccine Among Refugees in the United States

et al. 2021

View full text Add to dashboard Cite

show abstract

“…However, providing immunization services is crucial to ensure protection from vaccine-preventable diseases. There is an urgent need for COVID-19 vaccines and therapeutic agents in low and middleincome countries [19][20][21]. Mass vaccination sites will be an important innovation in the containment of the COVID-19 pandemic, but only if the effectiveness and safety of vaccination are ensured [22,23].…”

Section: Discussionmentioning

confidence: 99%

The efficacy and safety of COVID-19 vaccine: A protocol of systematic review and meta-analysis

Xue

Deng

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: The coronavirus disease 2019 (COVID-19) is one of the most wide-spread and threatening infectious diseases in human history. Experts in the field of medicine and biology are working to develop methods to treat and prevent COVID-19. Currently, COVID-19 is predominantly treated with symptomatic therapy and there is still a lack of effective antiviral therapy. Therefore, the prevention and control of novel coronavirus is primarily focused on vaccine development. Several vaccines have been developed, but their relative efficacy and safety have not been proven. Therefore, the aim of this study is to investigate the efficacy and safety of COVID-19 vaccines.Methods and analysis: The electronic databases we will use to retrieve information include PubMed, The Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), Wanfang Database and Weipu Electronics. The retrieval period is from the establishment of the database to March 2021. All randomized controlled trials in humans vaccinated with COVID-19 were collected, and data were independently selected and extracted according to predesigned inclusion/exclusion criteria. Full-text screening, data extraction and quality assessment were conducted independently by two reviewers. Two additional investigators will conduct report quality, risk of bias, sensitivity analysis and subgroup analysis to ensure the reliability of our study results. The software RevMan 5.3 was used for statistical analysis. Systematic review and meta-analyses will be conducted to evaluate the pooled evidence of efficacy and safety of the COVID-19 vaccines.Result: This study will evaluate the efficacy and safety of the COVID-19 vaccines.Conclusion: The conclusions of this study will provide an evidence-based analysis of the safety and efficacy of COVID-19 vaccines.Systematic review registration: PROSPERO CRD42021242581

show abstract

“…Researchers have previously called for the use of a common framework1516 that adopts existing methods including the International Standard Classification of Occupations40 and the International Classification of Diseases 41. As covid-19 vaccine rollout continues, it will be important to monitor vaccine uptake in these groups and ensure that they are included in the national response of the host country 42…”

Section: Strengthening the Evidence To Improve Healthmentioning

confidence: 99%

“…41 As covid-19 vaccine rollout continues, it will be important to monitor vaccine uptake in these groups and ensure that they are included in the national response of the host country. 42 When it is possible to anonymise data, existing public and private data on the health of migrant labourers should be used to better understand their health risks and the effect of social conditions on their health-for example, the recent disproportionate effect of covid-19 on migrant workers in overcrowded accommodation. 1 Retrospective analyses of national datasets and datasets of private companies could examine health needs, injuries, and deaths.…”

Section: Evidence On Health Needsmentioning

confidence: 99%